| Literature DB >> 28508244 |
M Duggal1,2, H J Tong3, M Al-Ansary4, W Twati4, P F Day4, H Nazzal4.
Abstract
AIM: This systematic review was undertaken in order to develop guidelines for the European Academy of Paediatric Dentistry for the management of non-vital permanent anterior teeth with incomplete root development.Entities:
Keywords: Calcium Hydroxide apexification; Endodontics; Immature non vital incisors; Mineral Trioxide aggregate; Regeneration/revitalisation; Trauamtized teeth
Mesh:
Year: 2017 PMID: 28508244 PMCID: PMC5488080 DOI: 10.1007/s40368-017-0289-5
Source DB: PubMed Journal: Eur Arch Paediatr Dent ISSN: 1818-6300
Characteristics of controlled calcium hydroxide apexification clinical studies
| Author | Level of evidence | n (Teeth) | Drop out | Age | Length of follow-up | Intervention | Outcome Success |
|---|---|---|---|---|---|---|---|
| (Roberts and Brilliant | 1- | Exp = 8 | 1 | Reported for each patient | No follow up after obturation | Ca(OH)2 and TCP | High success numbers too small for conclusion |
| (Mackie et al. | 2 | Exp = 19 | 3 | 6–10 | No follow up after apical closure | Two Ca(OH)2 pastes | 100% |
| (Coviello and Brilliant | 1- | Exp = 42 | 14 | Not defined | 9 months | Ca(OH)2 + TCP & Ca(OH)2 Apexification | 82% with Ca(OH)2 + TCP |
| (Yates | 1- | Exp = 22 | NR | Mean 10.3 | 1–7 years | Ca(OH)2 Apexification | 100% with 9 months better formation |
| (Merglova | 1- | Exp = 103 | NR | 6–15 | 1–4 years | Ca(OH)2 Apexification | 94.2% |
| (Dominguez Reyes et al. | 1- | Exp = 26 | 1 | 6–9 | No follow up after obturation | Ca(OH)2 Apexification | 100% |
NR Not reported; TCP Tricalcium phosphate
Fig. 1Success of calcium hydroxide apexification in three studies
Characteristics of clinical studies evaluating the use of MTA to facilitate obturation of root canal
| Author | Level of evidence | n (Teeth) | Drop out rate | Age | Follow-up (months) | Intervention | Out comes success |
|---|---|---|---|---|---|---|---|
| Lindeboom et al. ( | 1- | 100 | NR | 17–64 | Follow-up after obturation 12m | MTA and IRM Apexification | MTA scored 92% success after one year |
| El-Meligy and Avery ( | 2 | 30 | NR | 6–12 | Follow-up after obturation 12m | Ca(OH)2 and MTA Apexification | 100% MTA |
| Pradhan et al. ( | 2 | Exp = 10 | NR | 8–15 | No follow-up | Ca(OH)2 and MTA Apexification | 100% |
| Simon et al. ( | 2 | 57 | NR | Mean 18 | Every 6 m for 24m & thereafter every 12 m for 48m | WMTA and GMTA Apexification | 81% with minimum 1 year follow-up |
| Pace et al. ( | 3 | 11 | NR | 11–32 | 1–2 yrs | Ca(OH)2/MTA Apexification | 10 out of 11 = 90.9% |
| Moore et al. ( | 1- | 22 | 0 | 7–12 | Follow-up after obturation for 12m & 18m | White MTA ProRoot(®) or white MTA Angelus MTA Apexification | Clinical success rate was 95.5% ProRoot Group: |
| Damle et al. ( | 1- | 30 | 0 | 8–12 | 12m | Ca(OH)2 and MTA Apexification | Clinical and radiographic: |
| Damle et al. ( | 1- | 30 | 3 | 6–18 | 12m | Ca(OH)2 and MTA Apexification | Clinical and radiographic calcific apical barrier: |
Cont Control; Exp Experimental; GMTA Grey mineral trioxide aggregate; WMTA White mineral trioxide aggregate; NR Not reported; m Months; n Number; Ca(OH) Calcium hydroxide
Characteristics of clinical studies evaluating the use of regenerative endodontic technique (RET)
| Study | Level of evidence | Aetiology | Age | Groups | Follow-up (months±SD) | Periapical healing | Continued | Dentinal thickening of walls | Apical closure |
|---|---|---|---|---|---|---|---|---|---|
| Bose et al. ( | 2- | Variable = 88 | – | T1 = RET TAP SNR | 0 to >36 | – | RET TAP and RET Ca(OH)2 produced significantly greater increases than MTA or NSRCT | RET TAP produced significantly greater differences than | – |
| Jadhav et al. ( | 1- | Trauma = 20 | 15–28 | T = RET TAP PRP + BC (n = 10) | 12 | T= | T= | T= | T= |
| Jeeruphan et al. ( | 2+ | Caries = 5 | T:12.9 ± 5 | T = RET TAP BC + Collaplug (n = 20) | T = 21 ± 12 | T = 80% (16/20) | T = 14.9% | T = 28.2% | – |
| Alobaid et al. ( | 2+ | Trauma = 24 | T = 8.8 ± 1.6 | T = RETb BC (n = 19) | T = 14 ± 8.5 | – | T = 0%a
| T = 20% (3/15)a
| NR |
| Nagata et al. ( | 1- | Trauma = 23 | 7–17 | T1 = RET TAP BC (n = 12) | 1–19 | T1 = 100% | T1 = 41.7% | T1 = 41.7% | T1 = 66.7% |
| Nagy et al. ( | 1- | Trauma = 36 | 9–13 | T1 = RET TAPD BC (n = 12) | 3–18 | T1 = 100% | – | – | T1 = 100% |
| Bezgin et al. ( | 1- | Trauma = 14 | 7–13 | T = RET TAPC PRP (n = 10) | 18 | T = 100% (7/7) | – | – | T = 70%; (7/10) |
| Narang et al. ( | 1- | NR | <20 | C = MTA (n = 5) | 6 and 12 | C = 40% +++ | C = 0% | C = 0% | C = 0% |
| 60% ++ | |||||||||
| T1 = RET TAP BC (n = 5) | T1 = 40% + | T1 = 60%+ | T1 = 50% + | T1 = 33.3% ++ | |||||
| 60% ++ | 40% ++ | 50% ++ | 66.6% +++ | ||||||
| T2 = RET TAP PRF (n = 5) | T2 = 98% +++ | T2 = 100%+++ | T2 = 40% ++ | T2 = 60%+ | |||||
| 2% ++ | 60% +++ | 40% ++ | |||||||
| T3 = RET TAP PRP collagen (n = 5) | T4 = 20% + | T3 = 60%+ | T3 = 80% + | T3 = 40%+ | |||||
| 80% ++ | 40% ++ | 20% ++ | 60% ++ |
+ Satisfactory, ++ good, +++ excellent, T test group, C control group, RET regenerative endodontic technique, BC Blood Clot, PRP platelet rich plasma, PRF platelet rich fibrin, TAB tri antibiotic paste (ciprofloxacin, minocycline, metronidazole), TAPC tri antibiotic paste (Ciprofloxacin, minocycline, cephaclor), TABD tri antibiotic paste (ciprofloxacin, doxycycline, metronidazole), Ca(OH) calcium hydroxide, FC ferric sulphate, MTA mineral trioxide aggregate, NSRCT conventional RCT with gutta purcha, GP gutta purcha only, FGF blood clot and an injectable hydrogel scaffold impregnated with basic fibroblast growth factor, UK unknown scaffold, NR not reported
aResults when a 20% or more increase in root dimension is deemed clinically significant, b varying intracanal medicament